AONC (American Oncology Network) Deferred Tax : $3 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is American Oncology Network Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

American Oncology Network's change in deferred tax for the three months ended in Dec. 2024 was $0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was $3 Mil.

American Oncology Network Deferred Tax Historical Data

The historical data trend for American Oncology Network's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oncology Network Deferred Tax Chart

American Oncology Network Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Deferred Tax

-1.18

0.79

0.38

2.73

American Oncology Network Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Deferred Tax	Get a 7-Day Free Trial						-	2.89	-0.32	-	0.16

American Oncology Network Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3 Mil.

American Oncology Network Deferred Tax Related Terms

Thank you for viewing the detailed overview of American Oncology Network's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

American Oncology Network Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » American Oncology Network Inc (OTCPK:AONC) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

N/A

Address

14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913

Website

https://www.aoncology.com

American Oncology Network Inc through its subsidiary companies and variable interest entities, is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services across 37 oncology practices located in twenty states. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services, clinical research, radiation oncology, and imaging.

Executives

Stephen Divers	director, officer: Chief Medical Officer	133 HARMONY PARK CIRCLE, HOT SPRINGS AZ 71913
Todd Schonherz	director, officer: Chief Executive Officer	14543 GLOBAL PARKWAY, 2ND FLOOR, FORT MEYERS FL 33913
Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
David H Gould	officer: Chief Financial Officer	7370 COLLEGE PARKWAY, SUITE 207, FORT MEYERS FL 33907
Erica Mallon	officer: General Counsel	14543 GLOBAL PARKWAY, SUITE 110, FORT MEYERS FL 33913
Shalin Shah	director	3402 W DR. MARTIN LUTHER KING JR. BLVD, TAMPA FL 33607
Vipul M Patel	director	11704 SE 15TH CIRCLE, OCALA FL 34480
Vance Wright-browne	director	22395 EDGEWATER DRIVE, PORT CHARLOTTE FL 33980
James Stith	director	ONE LETTERMAN DRIVE, CM200, SAN FRANCISCO CA 94129
Aea Growth Equity Fund Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Aea Growth Equity Fund (parallel) Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Ravi Yang Sarin	director	C/O ARES MANAGEMENT LLC, 2000 AVENUE OF THE STARS, 12TH FLOOR, LOS ANGELES CA 90067
Brian R Hoesterey	10 percent owner	C/O AEA INVESTORS LP, 666 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10103
Kevin Nazemi	director, officer: Chief Executive Officer	10485 NE 6TH ST, UNIT 3930, BELLEVUE WA 98004